$1.58
At close: Apr 11, 4:04 PM EDT
$1.55
-0.03-1.90%
Pre-Market: Apr 11, 4:04 PM EDT
Comments
Loading...
Aprea Therapeutics Insider Trading Activity | NASDAQ:APRE | Benzinga
Track the latest Aprea Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Aprea Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Aprea Therapeutics Inc Insiders Doing?
At Aprea Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 5.50K shares for a total value of $10.11K.
Notable Recent Insider Buys and Sales
- On April 4, 2025, Oren Gilad, the company's PRESIDENT/CEO purchased 5.5K shares for $1.84 each.
Ownership Statistics for Aprea Therapeutics Inc
Shares Outstanding
5.435M
Insider Shares Owned
1.248M
Insider Percentage Owned
23.0%
Institutional Shares Held
359.337K
Institutional Percentage Held
6.61%
| Apr 04, 2025 | Oren Gilad | PRESIDENT/CEO | 5.50K | $1.84 | $10.11K | BUY | 1.61% | 346.22K | Apr 03 | View |
| Oct 25, 2024 | Marc Duey | DIRECTOR | -6.46K | $4.58 | -$29.58K | SELL | -2.68% | 234.25K | Oct 18 | View |
| Oct 24, 2024 | Oren Gilad | PRESIDENT/CEO | 500.00 | $3.92 | $1.96K | BUY | 0.15% | 334.00K | Oct 23 | View |
| Oct 17, 2024 | Marc Duey | DIRECTOR | 30.00K | $4.39 | $131.70K | BUY | 14.24% | 240.72K | Oct 16 | View |
| Oct 16, 2024 | Oren Gilad | PRESIDENT/CEO | 250.00 | $2.90 | $725.00 | BUY | 0.08% | 333.50K | Oct 15 | View |
| Oct 16, 2024 | Marc Duey | DIRECTOR | 190.00 | $2.58 | $490.20 | BUY | 0.09% | 210.72K | Oct 14 | View |
| Oct 16, 2024 | John Hamill | SRVP/CFO/PRIN FIN & ACCT OFCR | 50.00 | $2.46 | $123.19 | BUY | 0.26% | 19.37K | Oct 11 | View |
| Oct 15, 2024 | Bernd Seizinger | DIRECTOR | 10.00K | $2.68 | $26.80K | BUY | 28.79% | 44.73K | Oct 11 | View |
| Oct 15, 2024 | Oren Gilad | PRESIDENT/CEO | 1.15K | $2.58 | $2.97K | BUY | 0.35% | 333.25K | Oct 10 - Oct 14 | View |
| Oct 15, 2024 | John Hamill | SRVP/CFO/PRIN FIN & ACCT OFCR | 450.00 | $2.61 | $1.17K | BUY | 2.38% | 19.32K | Oct 10 | View |
| Mar 14, 2024 | John Hamill | SRVP/CFO/PRIN FIN & ACCT OFCR | 1.01K | $7.29 | $7.36K | BUY | 6.97% | 15.50K | Mar 13 | View |
| Mar 14, 2024 | Bernd Seizinger | DIRECTOR | 6.86K | $7.29 | $50.01K | BUY | 25.57% | 33.69K | Mar 13 | View |
| Mar 14, 2024 | JOHN HENNEMAN III | DIRECTOR | 6.86K | $7.29 | $50.01K | BUY | 536.36% | 8.14K | Mar 13 | View |
| Mar 14, 2024 | Oren Gilad | PRESIDENT, CEO | 2.00K | $7.29 | $14.58K | BUY | 0.62% | 324.77K | Mar 13 | View |
| Jun 08, 2023 | Bernd Seizinger | DIRECTOR | 10.10K | $3.66 | $36.96K | BUY | 62.22% | 26.32K | Jun 06 - Jun 07 | View |
| May 19, 2022 | Bernd Seizinger | DIRECTOR | 50.00K | $0.71 | $35.50K | BUY | 18.62% | 318.58K | May 18 | View |
| May 19, 2022 | CHRISTIAN SCHADE | CHAIRMAN & CEO | 37.50K | $0.64 | $24.12K | BUY | 14.42% | 297.62K | May 18 | View |
| Mar 01, 2022 | Eyal Attar | SVP, CHIEF MEDICAL OFFICER | -36.00K | $1.73 | -$62.28K | SELL | -43.29% | 47.16K | Feb 28 | View |
| Dec 03, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0.00 | $2.44 | -$83.60K | SELL-OPTIONS | 0.00% | 17.17K | Dec 01 | View |
| Nov 03, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0.00 | $2.96 | -$112.20K | SELL-OPTIONS | 0.00% | 17.17K | Nov 01 | View |
| Oct 05, 2021 | Lars Abrahmsen | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $2.90 | -$198.50K | SELL-OPTIONS | 0.00% | 19.00K | Oct 01 | View |
| Oct 05, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | 0.00 | $2.90 | -$109.17K | SELL-OPTIONS | 0.00% | 17.17K | Oct 01 | View |
| Sep 22, 2021 | Alan Gregory Korbel | SVP, CHIEF BUSINESS OFFICER | -5.46K | $2.95 | -$138.57K | SELL | -24.13% | 17.17K | Sep 20 | View |
| Sep 22, 2021 | Lars Abrahmsen | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $2.94 | -$101.25K | SELL-OPTIONS | 0.00% | 19.00K | Sep 20 | View |
| Sep 20, 2021 | Eyal Attar | SVP, CHIEF MEDICAL OFFICER | -15.97K | $4.68 | -$74.73K | SELL | -16.11% | 83.16K | Sep 16 | View |
| Feb 16, 2021 | Redmile Group LLCJeremy Green | 10% OWNER | -500.00K | $5.58 | -$2.79M | SELL | -22.04% | 1.77M | Dec 28 | View |
| Oct 07, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCAM Opportunities I LPAM Opportunities I GP LLCJOHN DIEKMANAndrew SchwabKUSH PARMARSCOTT ROCKLAGE | — | -175.00K | $25.30 | -$4.43M | SELL | -44.93% | 214.46K | Oct 05 | View |
| Jul 07, 2020 | AB Investments KDevAB Development KarolinskaKB Fund CoInvestment KCIF | — | -241.70K | $34.55 | -$8.35M | SELL | -10.82% | 1.99M | Jul 07 | View |
| Jun 18, 2020 | Scott M Rocklage | — | -120.16K | $33.30 | -$4.00M | SELL | -61.27% | 75.97K | Jun 16 | View |
| Jun 18, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCJOHN DIEKMANAndrew SchwabAM Opportunities I LPAM Opportunities I GP LLCKUSH PARMAR | — | -140.00K | $33.30 | -$4.66M | SELL | -30.87% | 313.50K | Jun 16 | View |
| Jun 15, 2020 | Scott M Rocklage | — | -245.00K | $28.75 | -$7.04M | SELL | -75.21% | 80.77K | Jun 11 | View |
| Jun 15, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCJOHN DIEKMANAndrew SchwabAM Opportunities I LPAM Opportunities I GP LLCKUSH PARMAR | — | -245.00K | $28.75 | -$7.04M | SELL | -37.17% | 414.11K | Jun 11 | View |
| May 21, 2020 | Scott M Rocklage | — | -255.00K | $35.15 | -$8.96M | SELL | -73.79% | 90.57K | May 19 | View |
| May 21, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCJOHN DIEKMANAndrew SchwabAM Opportunities I LPAM Opportunities I GP LLCKUSH PARMAR | — | -255.00K | $35.15 | -$8.96M | SELL | -37.56% | 423.90K | May 19 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.